Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.49 |
| ▸ | AR | P10275 | 9/20 | 0.39 |
| ▸ | IGLV6-57 | P01721 | 1/20 | 0.36 |
| ▸ | GRK6 | P43250 | 1/20 | 0.35 |
| ▸ | PARP15 | Q460N3 | 2/20 | 0.32 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.32 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | DAO | P14920 | 2/20 | 0.31 |
| ▸ | METAP2 | P50579 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17142228 | 0.92 | KDM4E (0.50) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL17142191 | 0.91 | KDM4E (0.49) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL17142184 | 0.90 | KDM4E (0.51) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL17142227 | 0.84 | KDM4E (0.54) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL17142193 | 0.75 | KDM4E (0.50) | KDM4ETDP1ARHSD17B10DAO | |
| SCHEMBL9244286 | 0.74 | KDM4E (0.67) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL3780116 | 0.74 | KDM4E (0.68) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL29421600 | 0.70 | KDM4E (0.80) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL3075296 | 0.70 | KDM4E (0.80) | KDM4ETDP1ARIGLV6-57GRK6 | |
| SCHEMBL5567066 | 0.70 | KDM4E (0.75) | KDM4ETDP1ARIGLV6-57GRK6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1497664-B1 | METHOD OF DETECTING AND LOCATING TRACES OF BLOOD AND A COMPOUND FOR DETECTING TRACES OF BLOOD | ROC IMP (MC) | 2007-03-21 | — | — | EP | claimed |
| EP-3129783-B1 | USE OF ABSORBENT PARTICLES FOR IMPROVING SIGNAL DETECTION IN AN ANALYSIS METHOD | BIO RAD EUROPE GMBH (CH) | 2021-06-02 | — | — | EP | disclosed |
| EP-3129782-B1 | CONTROL MARKER FOR IMPLEMENTING METHODS OF ANALYSIS ON SPOTS | BIO RAD EUROPE GMBH (CH) | 2021-01-06 | — | — | EP | disclosed |
| EP-3129784-A1 | USE OF A COLORANT IN ORDER TO IMPROVE SIGNAL DETECTION IN AN ANALYSIS METHOD | Bio-Rad Innovations (FR) | 2017-02-15 | — | — | EP | disclosed |
| EP-3129782-A1 | CONTROL MARKER FOR IMPLEMENTING ANALYSIS METHODS ON SPOTS | Bio-Rad Innovations (FR) | 2017-02-15 | — | — | EP | disclosed |
| EP-3129783-A1 | USE OF ABSORBENT PARTICLES IN ORDER TO IMPROVE SIGNAL DETECTION IN AN ANALYSIS METHOD | Bio-Rad Innovations (FR) | 2017-02-15 | — | — | EP | disclosed |
| EP-3126832-A1 | CONTROL MEANS FOR IMPLEMENTING MULTIPLEX ANALYSIS METHODS | Bio-Rad Innovations (FR) | 2017-02-08 | — | — | EP | disclosed |
| WO-2015155248-A1 | USE OF A COLORANT IN ORDER TO IMPROVE SIGNAL DETECTION IN AN ANALYSIS METHOD | BIO-RAD INNOVATIONS (FR) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015155254-A1 | CONTROL MARKER FOR IMPLEMENTING ANALYSIS METHODS ON SPOTS | BIO-RAD INNOVATIONS (FR) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015155255-A1 | USE OF ABSORBENT PARTICLES IN ORDER TO IMPROVE SIGNAL DETECTION IN AN ANALYSIS METHOD | BIO-RAD INNOVATIONS (FR) | 2015-10-15 | — | — | WO | disclosed |
| WO-2015150583-A1 | CONTROL MEANS FOR IMPLEMENTING MULTIPLEX ANALYSIS METHODS | BIO-RAD INNOVATIONS (FR) | 2015-10-08 | — | — | WO | disclosed |
| US-8183060-B2 | comprises biotin covalently attached to a polymer that has monosaccharide or amino acid as a constituent monomer covalently attached to a luminescent substance (cyanoisoindoles, luminols, and acridinium esters); detecting a target substance at high sensitivity | DAIICHI PURE CHEMICALS CO., LTD. (JP) | 2012-05-22 | — | — | US | disclosed |